Sift Biosciences

Sift Biosciences is a healthcare company in Seattle, United States, founded in 2024. It has raised $3.7M across 1 round, most recently a $3.7M Pre-Seed in February 2026.

Harnessing hidden immunity to fight cancer and autoimmunity.

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$3.7M
Last Round
$3.7M Pre-SeedFeb 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Sift Biosciences is a San Carlos, California-based peptide immunotherapy company spun out of UC Berkeley. The company has built a proprietary platform combining AI-driven discovery, metagenomics, and high-throughput T-cell screening to identify microbially derived peptides that activate pre-existing memory T cells capable of targeting cancer and autoimmune diseases. By borrowing signals from bacteria and viruses that frequently interact with the human immune system, Sift aims to develop a new class of targeted, durable immunotherapies for cancers and autoimmune conditions where current therapies fall short. The company raised $3.7M in an oversubscribed pre-seed round in early 2026 and was co-founded by Yue Clare Lou, Ph.D. (Forbes 30 Under 30) and Maddie Williams.

Summary

It lists 1–10 employees. It has raised $3.7M in total across 1 round, most recently a $3.7M Pre-Seed round in Feb 2026. Investors include Freeflow Ventures, Lifespan Vision Ventures and SBI US Gateway Fund.

Funding History

Data from Indexed.vcUpdated
Pre-seedPre-SeedFeb 2026
$3.7M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sift Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/sift-biosciences"><img src="https://indexed.vc/api/badge/company/sift-biosciences" alt="Sift Biosciences on Indexed.vc" width="260" height="76" /></a>